We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
162 hedge funds and large institutions have $775M invested in Arcturus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 51 increasing their positions, 40 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
104% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 26
28% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 40
24% more call options, than puts
Call options by funds: $31.2M | Put options by funds: $25.2M
20% more funds holding
Funds holding: 135 → 162 (+27)
5.43% less ownership
Funds ownership: 76.92% → 71.49% (-5.4%)
10% less capital invested
Capital invested by funds: $865M → $775M (-$89.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
162
Holders Change
+27
Holders Change %
+20%
% of All Funds
2.84%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
53
Increased
51
Reduced
40
Closed
26
Calls
$31.2M
Puts
$25.2M
Net Calls
+$6.08M
Net Calls Change
-$3.63M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$23M |
| 2 |
Voloridge Investment Management
Jupiter,
Florida
|
+$14.2M |
| 3 |
Two Sigma Investments
New York
|
+$13.7M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$10.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.08M |
